---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-032873"
form_type: "8-K"
ticker: null
cik: "0001537561"
company_name: "Arch Therapeutics, Inc."
filed_at: "2024-08-16T23:59:59+00:00"
generated_at: "2026-05-31T08:50:08.799913+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Punit Dhillon resigns from Arch Therapeutics Board effective August 14, 2024

## Summary
- Punit Dhillon resigned as a member of the Board effective August 14, 2024.
- No disagreements between the Company and Mr. Dhillon related to his resignation.
- No replacement named; the filing does not provide further details.

## SEC filing metadata
- accession: 0001493152-24-032873
- form_type: 8-K
- cik: 0001537561
- company_name: Arch Therapeutics, Inc.
- filed_at: 2024-08-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1537561/000149315224032873/0001493152-24-032873-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1537561/000149315224032873/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-032873
- JSON: https://secwatch.observer/filing/0001493152-24-032873.json
- Plain text: https://secwatch.observer/filing/0001493152-24-032873.txt

## Key facts
- Executive change
  Punit Dhillon resigned as member of the Board at Arch Therapeutics, Inc..
  - Action: resigned
  - Role: member of the Board
  source text: On August 14, 2024, Punit Dhillon notified the board of directors (the “Board”) of Arch Therapeutics, Inc. (the “Company”) that he will resign as a member of the Board effective August 14, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1537561/000149315224032873/0001493152-24-032873-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.